Afamelanotide

Use the mouse wheel or two fingers (on touchscreens) to zoom in and out of the map.

Map view:

Zoom: 100%

More settings

Connection length 100% Label size 100% Node size 100% Line width 100% Label width 100%

Export map as:

Afamelanotide topic overview

The analysis highlights History, Adverse effects and Pharmacology as prominent areas in the source structure around Afamelanotide.

Related topics: 71
Source areas: 5
Connected nodes: 76
Extracted relationships: 57
Concept neighborhoods: 21
Bridge connections: 76

What this topic covers Research coverage

Source areas are shown by the number of related topics found in each part of the analysis. Use smaller areas too: they can reveal specialized angles and content gaps.

Adverse effects · 37 topics

History · 19 topics

Overview · 10 topics

Pharmacology · 3 topics

Chemistry · 2 topics

Smaller areas are not necessarily less important. They contain fewer connections in this analysis and can be useful for finding specialized angles or coverage gaps.

Key facts & relationships

High-confidence facts extracted from structured source data. Use them as anchors for further research.

3D model (JSmol): Interactive image
AHFS/Drugs.com: Monograph
ATC code: D02BB02 (WHO)
CAS Number: 75921-69-6 N
ChEBI: CHEBI:136034
ChEMBL: ChEMBL441738 Y

Explore all related topics Closing gaps

Browse the complete topic structure, not only the most central items. Less prominent entities and concepts can reveal missing angles, specialized context and useful research gaps. Each item opens a new analysis centered on that subject.

Overview

History

Advanced semantic analysis

Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.

How Afamelanotide connects Entity context

The extracted context around Afamelanotide shows recurring relationship patterns in the source. For example, Afamelanotide → Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2, D-Phe7, It, MSH, NDP-MSH, NDP-α-MSH, Nle4 Another extracted example is Afamelanotide → Arizona, By, II, In, Later, MSH, University. Use these groups to spot repeated connection types before inspecting the individual relationships.

Top relations

related to Chemistry · 7

Afamelanotide → Ac-Ser-Tyr-Ser-Nle-Glu-His-D-Phe-Arg-Trp-Gly-Lys-Pro-Val-NH2, D-Phe7, It, MSH, NDP-MSH, NDP-α-MSH, Nle4

related to history · 7

Afamelanotide → Arizona, By, II, In, Later, MSH, University

related to Pharmacology · 7

Afamelanotide → After, By, It, Its, MC1, MSH, This

Legal status · 4

Afamelanotide → AU: S4 (Prescription only), EU: Rx-only, UK: POM (Prescription only), US: ℞-only

has effect · 3

Afamelanotide → Other, The, Uncommon

related to Medical uses · 3

Afamelanotide → European Union, In, United States

KEGG · 2

Afamelanotide → as salt: D11334 N, D10511 N

is a · 2

Afamelanotide → international nonproprietary name, melanocortin 1 receptor

3D model (JSmol) · 1

Afamelanotide → Interactive image

AHFS/Drugs.com · 1

Afamelanotide → Monograph

Important terminology

Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.

Important terminology

trials effects erythropoietic protoporphyria skin drug us name light exposure phototoxicity adverse α-msh half-life peptide reactions clinical clinuvel sold medication

Afamelanotide relationships Subject–Predicate–Object triples

TTTA extracted 57 structured relationships around Afamelanotide. Examples in this analysis include Afamelanotide → 3D model (JSmol) → Interactive image and Afamelanotide → AHFS/Drugs.com → Monograph. The table shows each extracted connection, where it came from and its confidence.

Subject	Predicate	Object	Confidence	Src
Afamelanotide	3D model (JSmol)	Interactive image	1.00	infobox
Afamelanotide	AHFS/Drugs.com	Monograph	1.00	infobox
Afamelanotide	ATC code	D02BB02 (WHO)	1.00	infobox
Afamelanotide	CAS Number	75921-69-6 N	1.00	infobox
Afamelanotide	ChEBI	CHEBI:136034	1.00	infobox
Afamelanotide	ChEMBL	ChEMBL441738 Y	1.00	infobox
Afamelanotide	ChemSpider	17310725 Y	1.00	infobox
Afamelanotide	CompTox Dashboard (EPA)	DTXSID40226843	1.00	infobox
Afamelanotide	DrugBank	DB04931	1.00	infobox
Afamelanotide	Elimination half-life	30 minutes	1.00	infobox
Afamelanotide	Formula	C78H111N21O19	1.00	infobox
Afamelanotide	IUPHAR/BPS	1324	1.00	infobox
Afamelanotide	KEGG	D10511 N	1.00	infobox
Afamelanotide	KEGG	as salt: D11334 N	1.00	infobox
Afamelanotide	Legal status	AU: S4 (Prescription only)	1.00	infobox
Afamelanotide	Legal status	UK: POM (Prescription only)	1.00	infobox
Afamelanotide	Legal status	US: ℞-only	1.00	infobox
Afamelanotide	Legal status	EU: Rx-only	1.00	infobox
Afamelanotide	License data	US DailyMed: Afamelanotide	1.00	infobox
Afamelanotide	Molar mass	1646.874 g·mol−1	1.00	infobox
Afamelanotide	Other names	[Nle4,D-Phe7]α-MSH; NDP-α-MSH; NDP-MSH; Melanotan; Melanotan-1; Melanotan I; EPT1647; CUV1647;	1.00	infobox
Afamelanotide	Pregnancy category	AU: B1	1.00	infobox
Afamelanotide	Pronunciation	/ˌæfəmɛˈlænoʊtaɪd/ ⓘ	1.00	infobox
Afamelanotide	PubChem CID	16154396	1.00	infobox
Afamelanotide	Routes of administration	Subcutaneous	1.00	infobox
Afamelanotide	Trade names	Scenesse	1.00	infobox
Afamelanotide	UNII	QW68W3J66U	1.00	infobox
Afamelanotide	is a	melanocortin 1 receptor	0.90	text
Afamelanotide	is a	international nonproprietary name	0.90	text

Related concept clusters Concept neighborhoods

The concept neighborhoods around Afamelanotide bring nearby vocabulary together. In this analysis, examples include Exposure, Erythropoietic and Protoporphyria. Use the clusters to find adjacent concepts and terminology that may deserve separate research.

Afamelanotide
- Exposure
- Erythropoietic
- Protoporphyria
- Phototoxicity
- Sun
- Name
- Α-msh
- Us
- Effects
- Analogue
- Scenesse
- Synthetic
afamelanotide
- Exposure
- Erythropoietic
- Protoporphyria
- Phototoxicity
- Sun
- Name
- Α-msh
- Us
- Effects
- Analogue
- Scenesse
- Synthetic
food and drug administration
- Us
- Day
- Drug
- Clinuvel
- Erythropoietic
- Protoporphyria
- Scenesse
- Subcutaneous
- Adults
- European
- Medication
- Pain
adverse effects
- Effects
- Reported
- Reactions
- Trials
- Clinical
- Light
- Scenesse
- Subcutaneous
- Us
- Administration
- Adults
- European
erythropoietic protoporphyria
- Protoporphyria
- Phototoxicity
- Exposure
- Light
- Scenesse
- Administration
- Adults
- Medication
- Pain
- Sun
- Name
- Us
international nonproprietary name
- Scenesse
- Phototoxicity
- Α-msh
- Erythropoietic
- Protoporphyria
- Subcutaneous
- Administration
- Adults
- European
- First
- Medication
- Pain
phototoxicity
- Scenesse
- Adults
- Erythropoietic
- Protoporphyria
- Exposure
- Light
- Subcutaneous
- Administration
- European
- Pain
- Sold
- Sun
back pain
- Sun
- Exposure
- Erythropoietic
- Protoporphyria
- Scenesse
- Administration
- Phototoxicity
- Reported
- Sold
- Adverse
- Clinical
- Light

Connections between topic areas Semantic bridges

For Afamelanotide, one of the stronger structural bridges in this analysis connects Afamelanotide with Adverse effects. Bridges highlight paths between different parts of the map and can reveal research angles that are easy to miss in a flat list.

Min side: 3

Afamelanotide — Adverse effects · splits 39 ⟂ 38

Afamelanotide — History · splits 57 ⟂ 20

Afamelanotide — Overview · splits 66 ⟂ 11

Afamelanotide — Pharmacology · splits 73 ⟂ 4

Afamelanotide — Chemistry · splits 74 ⟂ 3

Map overview Semantic statistics

Afamelanotide

Nodes77

Edges76

Triples57

Avg. degree1.97

Density0.025974

Components1

Source & methodology

TTTA analyzes the structure around Afamelanotide to surface related topics, entities, relationships, concept neighborhoods and bridge connections. Use the map to explore areas such as History, Adverse effects & Pharmacology, including less central topics that may reveal useful research gaps. Automatically extracted connections are research leads rather than rewritten encyclopedia content.

Source: Wikipedia — Afamelanotide · EN edition · Analysis: TopicsToTalkAbout